Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity
- PMID: 15607965
- DOI: 10.1016/j.ccr.2004.11.012
Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity
Abstract
ONYX-015 is an adenovirus that lacks the E1B-55K gene product for p53 degradation. Thus, ONYX-015 was conceived as an oncolytic virus that would selectively replicate in p53-defective tumor cells. Here we show that loss of E1B-55K leads to the induction, but not the activation, of p53 in ONYX-015-infected primary cells. We use a novel adenovirus mutant, ONYX-053, to demonstrate that loss of E1B-55K-mediated late viral RNA export, rather than p53 degradation, restricts ONYX-015 replication in primary cells. In contrast, we show that tumor cells that support ONYX-015 replication provide the RNA export function of E1B-55K. These data reveal that tumor cells have altered mechanisms for RNA export and resolve the controversial role of p53 in governing ONYX-015 oncolytic selectivity.
Similar articles
-
Heat shock phenocopies E1B-55K late functions and selectively sensitizes refractory tumor cells to ONYX-015 oncolytic viral therapy.Cancer Cell. 2005 Jul;8(1):61-74. doi: 10.1016/j.ccr.2005.06.009. Cancer Cell. 2005. PMID: 16023599
-
Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein.J Virol. 2001 May;75(9):4297-307. doi: 10.1128/JVI.75.9.4297-4307.2001. J Virol. 2001. PMID: 11287579 Free PMC article.
-
p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.J Virol. 1999 Jul;73(7):5333-44. doi: 10.1128/JVI.73.7.5333-5344.1999. J Virol. 1999. PMID: 10364280 Free PMC article.
-
Interactions between adenovirus proteins and the p53 pathway: the development of ONYX-015.Semin Cancer Biol. 2000 Dec;10(6):453-9. doi: 10.1006/scbi.2000.0336. Semin Cancer Biol. 2000. PMID: 11170867 Review.
-
Genetically modified adenoviruses against gliomas: from bench to bedside.Neurology. 2004 Aug 10;63(3):418-26. doi: 10.1212/01.wnl.0000133302.15022.7f. Neurology. 2004. PMID: 15304571 Review.
Cited by
-
Adenovirus E4-ORF3 Targets PIAS3 and Together with E1B-55K Remodels SUMO Interactions in the Nucleus and at Virus Genome Replication Domains.J Virol. 2015 Oct;89(20):10260-72. doi: 10.1128/JVI.01091-15. Epub 2015 Jul 29. J Virol. 2015. PMID: 26223632 Free PMC article.
-
Strength in Diversity: Nuclear Export of Viral RNAs.Viruses. 2020 Sep 11;12(9):1014. doi: 10.3390/v12091014. Viruses. 2020. PMID: 32932882 Free PMC article. Review.
-
LKB1 Tumor Suppressor: Therapeutic Opportunities Knock when LKB1 Is Inactivated.Genes Dis. 2014 Sep 1;1(1):64-74. doi: 10.1016/j.gendis.2014.06.002. Genes Dis. 2014. PMID: 25679014 Free PMC article.
-
A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.Oncotarget. 2015 May 30;6(15):13564-78. doi: 10.18632/oncotarget.3769. Oncotarget. 2015. PMID: 25980438 Free PMC article.
-
Reovirus: a targeted therapeutic--progress and potential.Mol Cancer Res. 2012 Dec;10(12):1514-25. doi: 10.1158/1541-7786.MCR-12-0157. Epub 2012 Oct 4. Mol Cancer Res. 2012. PMID: 23038811 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous